Rivaroxaban for Antiphospholipid Antibody Syndrome

NCT02116036 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Antiphospholipid Antibody Syndrome

Interventions

DRUG: Rivaroxaban

Sponsor

St. Joseph's Healthcare Hamilton

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]